What You Should Know:
– Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology.
– Leveraging the power of Paige’s Foundation…
Continue Reading
Digital twins, innovative virtual models synthesizing real-time biological, environmental, and lifestyle data, herald a new era in personalized medicine, particularly dermatology. These models, integrating medical-purpose Internet of Things (IoT) devices, deep and digital phenotyping,…
Continue Reading
The following is a guest article by Dave Werry, Co-Founder & President at Well
Personalized healthcare continues to become more ubiquitous, and its well-documented benefits include greater health outcomes, enhanced convenience, and reduced employer costs….
What You Should Know: – Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care. – The survey of 475 patients explored attitudes…
Continue Reading
Cleveland Clinic and the Novo Nordisk Foundation have announced a new academic partnership focusing on leading-edge IT research and its clinical applications. The three-year opportunity is aimed at early-stage researchers working at the intersection…
Continue Reading
Dr. Elizabeth Reed Aden, a PHD and a former pharma industry executive and the author of The Goldilock Genome joins eHealth Radio and the Health News and Pharmaceutical Channels.
Listen to interview with host Eric…
What You Should Know:
– OncoHost, a company pioneering personalized medicine approaches for better patient outcomes, announced a collaborative research study with Dana-Farber Cancer Institute, a leading cancer treatment and research center.
– The project aims…
Continue Reading
What You Should Know:
– OM1 introduces three new products: OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM – an artificial intelligence-powered digital phenotyping platform for personalized medicine and clinical research.
– OM1 is…
Continue Reading
Cardiac digital twins provide a physics and physiology informed framework to deliver personalized medicine. However, high-fidelity multi-scale cardiac models remain a barrier to adoption due to their extensive computational costs. Artificial Intelligence-based methods can…
Continue Reading
What You Should Know:
– Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA.
– The investment brings Nucleai’s total funding to $60M…
Continue Reading
